Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company [Seeking Alpha]
Kenvue Inc. (KVUE)
Company Research
Source: Seeking Alpha
In this update, I take a look at Kenvue's results to date and discuss what to expect from the upcoming report. I also outline my longer-term expectations for Kenvue and take a look at the company's brand portfolio, balance sheet quality and current profitability. I discuss a sign that Kenvue's management may be saving in the wrong places and share why investors should keep an eye on R&D and advertising spending. Since the stock is down 10% since my last article, I'll also share whether I now consider KVUE stock a buy. Introduction Kenvue Inc. NYSE: KVUE ), the former Consumer Health division of "super-SWAN" company Johnson & Johnson ( JNJ ), will release its fourth-quarter and full-year 2023 results on Thursday, February 8 . No doubt it will be an exciting report, as it will be the first full-year earnings announcement as a standalone company. In this update, I'll take a look at Kenvue's results to date and discuss what to expect from the upcoming report. In addition, I'l
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue Declares Quarterly Cash DividendBusiness Wire
- J&J Profit Beats Estimates as Pharma Sales Edge Out Street [BNN Bloomberg (Canada)]BNN Bloomberg
- Zimbabwe Recalls Tainted J&J's Cough Syrup Sold in Six African Nations [BNN Bloomberg (Canada)]BNN Bloomberg
- J&J's Tainted Cough Syrup Was Sold in Six African Countries [BNN Bloomberg (Canada)]BNN Bloomberg
- Kenvue Inc. (NYSE: KVUE) is now covered by analysts at Sanford C. Bernstein. They set an "underperform" rating and a $18.00 price target on the stock.MarketBeat
KVUE
Earnings
- 2/8/24 - Beat
KVUE
Sec Filings
- 4/10/24 - Form ARS
- 4/10/24 - Form DEFA14A
- 4/10/24 - Form DEF
- KVUE's page on the SEC website